chr3-12516627-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP5
The NM_025265.4(TSEN2):āc.926A>Gā(p.Tyr309Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000502 in 1,613,986 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: š 0.000020 ( 0 hom., cov: 31)
Exomes š: 0.000053 ( 1 hom. )
Consequence
TSEN2
NM_025265.4 missense
NM_025265.4 missense
Scores
12
6
1
Clinical Significance
Conservation
PhyloP100: 6.42
Genes affected
TSEN2 (HGNC:28422): (tRNA splicing endonuclease subunit 2) This gene encodes one of the subunits of the tRNA splicing endonuclease. This endonuclease catalyzes the first step in RNA splicing which is the removal of introns. Mutations in this gene have been associated with pontocerebellar hypoplasia type 2. A pseudogene has been identified on chromosome 4. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 3-12516627-A-G is Pathogenic according to our data. Variant chr3-12516627-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 2125.We mark this variant Likely_pathogenic, oryginal submissions are: {Uncertain_significance=2, Pathogenic=1, not_provided=1, Likely_pathogenic=2}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TSEN2 | NM_025265.4 | c.926A>G | p.Tyr309Cys | missense_variant | 7/12 | ENST00000284995.11 | NP_079541.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TSEN2 | ENST00000284995.11 | c.926A>G | p.Tyr309Cys | missense_variant | 7/12 | 1 | NM_025265.4 | ENSP00000284995.6 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152028Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
3
AN:
152028
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000139 AC: 35AN: 251398Hom.: 1 AF XY: 0.000103 AC XY: 14AN XY: 135876
GnomAD3 exomes
AF:
AC:
35
AN:
251398
Hom.:
AF XY:
AC XY:
14
AN XY:
135876
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000534 AC: 78AN: 1461842Hom.: 1 Cov.: 31 AF XY: 0.0000605 AC XY: 44AN XY: 727220
GnomAD4 exome
AF:
AC:
78
AN:
1461842
Hom.:
Cov.:
31
AF XY:
AC XY:
44
AN XY:
727220
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152144Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74380
GnomAD4 genome
AF:
AC:
3
AN:
152144
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
74380
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
20
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:4Uncertain:2Other:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Pontocerebellar hypoplasia type 2B Pathogenic:3Other:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | - | - - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Genomic Research Center, Shahid Beheshti University of Medical Sciences | Dec 18, 2017 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 01, 2011 | - - |
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 09, 2022 | ClinVar contains an entry for this variant (Variation ID: 2125). This missense change has been observed in individual(s) with pontocerebellar hypoplasias (PMID: 18711368, 20952379). This variant is present in population databases (rs113994149, gnomAD 0.06%), and has an allele count higher than expected for a pathogenic variant. This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 309 of the TSEN2 protein (p.Tyr309Cys). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | May 10, 2024 | Observed with a second TSEN2 variant in a patient with pontocerebellar hypoplasia, but it is not known whether the variants occurred on the same (in cis) or on different (in trans) chromosomes (PMID: 20952379); Published functional studies suggest Y309C affects thermal stability (PMID: 34584079); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 20952379, 18711368, 34584079, 38347586) - |
Pontoneocerebellar hypoplasia Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jan 09, 2022 | Variant summary: TSEN2 c.926A>G (p.Tyr309Cys) results in a non-conservative amino acid change located in the tRNA intron endonuclease, N-terminal domain (IPR006678) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. Multiple sequence alignment of human TSEN2 with the corresponding sequences of a broad range of other organisms showed that the Tyr309 position is strictly conserved (tyrosine or phenylalanine) within eukaryotic organisms (Budde_2008). The variant allele was found at a frequency of 0.00014 in 251398 control chromosomes in the gnomAD database, including 1 homozygote. This frequency is not significantly higher than estimated for a pathogenic variant in TSEN2 causing Pontocerebellar Hypoplasia, Type 2B (0.00014 vs 0.0011), allowing no conclusion about variant significance. Moreover, the single homozygote observed in gnomAD database has been reported as not a true homozygote due to one read supporting a reference base (Tarailo-Graovac_2017). c.926A>G has been reported in the literature as a homozygous and compound heterozygous genotype in individuals affected with Pontocerebellar Hypoplasia, Type 2B (example, Budde_2008, Namavar_2011). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. One laboratory classified the variant as pathogenic and one laboratory classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
D;.;D;.;D;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
D;D;.;D;D;D
M_CAP
Uncertain
D
MetaRNN
Uncertain
D;D;D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
.;.;M;.;M;.
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D;D;D;D;D
REVEL
Pathogenic
Sift
Pathogenic
D;D;D;D;D;D
Sift4G
Pathogenic
D;D;D;D;D;D
Polyphen
1.0
.;.;D;.;D;D
Vest4
0.95, 0.97, 0.96, 0.98
MVP
MPC
0.25
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at